Cite
HARVARD Citation
Hurabielle, C. et al. (2017). Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease. British journal of dermatology. pp. e206-e208. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hurabielle, C. et al. (2017). Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease. British journal of dermatology. pp. e206-e208. [Online].